pharmaceuticals

Eli Lilly Boosts 2025 Forecast with Soaring Mounjaro and Zepbound Sales: Quarterly Results Exceed Expectations!
Eli Lilly recently announced impressive second-quarter results, surpassing expectations mainly due to strong sales of its weight loss and diabetes ... Read more

Eli Lilly’s Breakthrough Obesity Pill Achieves 12% Weight Loss in Key Late-Stage Trial: A Game Changer for Weight Management
Eli Lilly recently shared exciting news about its new weight loss pill. In a late-stage trial, the highest dose helped ... Read more

Trump Warns: Pharma Tariffs Could Soar to 250%—What This Means for You
President Donald Trump recently discussed potential tariffs on imported pharmaceuticals during an interview with CNBC. He mentioned that these tariffs ... Read more

Pfizer Boosts 2025 Profit Forecast: Discover How Cost Cuts and Stellar Quarterly Results Drive Growth
Pfizer recently raised its profit outlook for the year, pointing to strong performance and successful cost-cutting measures. The company now ... Read more

Moderna Adjusts 2025 Revenue Forecast Due to UK Vaccine Shipment Delays: What It Means for Investors
Moderna recently adjusted its revenue forecast for 2025, lowering expectations due to delays in vaccine shipments to the U.K. Even ... Read more

Breaking News: Vinay Prasad Leaves the FDA—What This Means for Public Health
Vinay Prasad, a key figure at the Food and Drug Administration (FDA), recently left his position amidst some heated discussions ... Read more

UnitedHealth Predicts Lower 2025 Earnings Amid Rising Medical Costs: What It Means for Insurers
UnitedHealth Group recently shared its outlook for 2025, and the news isn’t great. The company anticipates adjusted earnings of at ... Read more

FDA Resumes Approval of Sarepta Therapeutics’ Duchenne Therapy for Younger Patients: What You Need to Know
The FDA has made a significant announcement regarding Sarepta Therapeutics’ gene therapy for Duchenne muscular dystrophy. Effective Monday, the agency ... Read more


